DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
AMINO ACIDS; MAGNESIUM ACETATE; POTASSIUM ACETATE; SODIUM CHLORIDE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
AMINO ACIDS; MAGNESIUM ACETATE; POTASSIUM ACETATE; SODIUM CHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MEPARFYNOL
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
MEPARFYNOL
×
Maximum Phase:
4
First Approval:
None
UNII:
B017BC5B1N
Molecule Type:
Small molecule
Molecular Formula:
C6H10O
Molecular Weight:
98.14
AlogP:
0.78
PSA:
20.23
HBD:
1.0
HBA:
#RotB:
1.0
Source:
CARBENOXOLONE SODIUM
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
CARBENOXOLONE SODIUM
×
Maximum Phase:
4
First Approval:
None
UNII:
F1MP7242Z5
Molecule Type:
Small molecule
Molecular Formula:
C34H48Na2O7
Molecular Weight:
614.73
AlogP:
6.83
PSA:
117.97
HBD:
2.0
HBA:
#RotB:
5.0
Source:
TRIBROMSALAN
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
TRIBROMSALAN
×
Maximum Phase:
4
First Approval:
None
UNII:
6MCE3VTF0O
Molecule Type:
Small molecule
Molecular Formula:
C13H8Br3NO2
Molecular Weight:
449.92
AlogP:
4.93
PSA:
49.33
HBD:
2.0
HBA:
#RotB:
2.0
Source:
ASPIRIN; OXYCODONE HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
ASPIRIN; OXYCODONE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
THROMBOPLASTIN
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
THROMBOPLASTIN
×
Maximum Phase:
4
First Approval:
None
UNII:
1U5PI2DLU1
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PREDNISOLONE ACETATE; SULFACETAMIDE SODIUM
4
Combination
Approved
OTHER
OPHTHALMIC
Unknown
Unknown
PREDNISOLONE ACETATE; SULFACETAMIDE SODIUM
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ATTAPULGITE, ACTIVATED
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
ATTAPULGITE, ACTIVATED
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PEGINESATIDE
4
Protein
Approved
Unknown
Unknown
Anemia
Erythropoietin receptor agonist
PEGINESATIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
JX56W9N61Q
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TEBENTAFUSP-TEBN
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
TEBENTAFUSP-TEBN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
METHYLATROPINE NITRATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
METHYLATROPINE NITRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Q48D9J47K2
Molecule Type:
Small molecule
Molecular Formula:
C18H26N2O6
Molecular Weight:
366.41
AlogP:
2.08
PSA:
46.53
HBD:
1.0
HBA:
#RotB:
4.0
Source:
METHOXYPHENAMINE
4
Small molecule
Approved
Unknown
Unknown
Lung Diseases, Obstructive
Unknown
METHOXYPHENAMINE
×
Maximum Phase:
4
First Approval:
None
UNII:
J3Z5SRI26Z
Molecule Type:
Small molecule
Molecular Formula:
C11H17NO
Molecular Weight:
179.26
AlogP:
1.85
PSA:
21.26
HBD:
1.0
HBA:
#RotB:
4.0
Source:
EPTACOG ALFA (ACTIVATED)
4
Protein
Approved
Unknown
Unknown
Cerebral Hemorrhage; Hemophilia B; Hemorrhagic Disorders; Factor VII Deficiency; Hemophilia A
Unknown
EPTACOG ALFA (ACTIVATED)
×
Maximum Phase:
4
First Approval:
None
UNII:
AC71R787OV
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CONESTAT ALFA
4
Protein
Unknown
Unknown
Unknown
Acute Kidney Injury; Genetic Diseases, Inborn; Graft vs Host Disease; Non-ST Elevated Myocardial Infarction; Severe Acute Respiratory Syndrome; Angioedemas, Hereditary
Unknown
CONESTAT ALFA
×
Maximum Phase:
4
First Approval:
None
UNII:
5QS67N4551
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GLYCOPYRROLATE ; INDACATEROL MALEATE
4
Combination
Approved
Unknown
INHALATION
Unknown
Unknown
GLYCOPYRROLATE ; INDACATEROL MALEATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ZOLEDRONATE
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
ZOLEDRONATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CALASPARGASE PEGOL-MKNL
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
CALASPARGASE PEGOL-MKNL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CYCLOPENTOLATE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE
4
Combination
Approved
OTHER
OPHTHALMIC
Unknown
Unknown
CYCLOPENTOLATE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PROGLUMIDE
4
Small molecule
Approved
Unknown
Unknown
Liver Cirrhosis; Non-alcoholic Fatty Liver Disease; Gastroesophageal Reflux; Peptic Ulcer
Cholecystokinin receptor antagonist
PROGLUMIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
EPL8W5565D
Molecule Type:
Small molecule
Molecular Formula:
C18H26N2O4
Molecular Weight:
334.42
AlogP:
2.3
PSA:
86.71
HBD:
2.0
HBA:
#RotB:
10.0
Source:
ETHAMIVAN
4
Small molecule
Approved
Unknown
Unknown
Respiratory Tract Diseases
Unknown
ETHAMIVAN
×
Maximum Phase:
4
First Approval:
None
UNII:
M44O63YPV9
Molecule Type:
Small molecule
Molecular Formula:
C12H17NO3
Molecular Weight:
223.27
AlogP:
1.88
PSA:
49.77
HBD:
1.0
HBA:
#RotB:
4.0
Source:
SUTIMLIMAB-JOME
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
SUTIMLIMAB-JOME
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
COD LIVER OIL
4
Small molecule
Approved
Unknown
Unknown
Unknown
Supplement
COD LIVER OIL
×
Maximum Phase:
4
First Approval:
None
UNII:
BBL281NWFG
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMINO ACIDS; CALCIUM ACETATE; GLYCERIN; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
AMINO ACIDS; CALCIUM ACETATE; GLYCERIN; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PHENOTHRIN
4
Small molecule
Approved
Unknown
Unknown
Ectoparasitic Infestations
Unknown
PHENOTHRIN
×
Maximum Phase:
4
First Approval:
None
UNII:
707484X33X
Molecule Type:
Small molecule
Molecular Formula:
C23H26O3
Molecular Weight:
350.46
AlogP:
5.76
PSA:
35.53
HBD:
0.0
HBA:
#RotB:
6.0
Source:
GLUCOMANNAN
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
GLUCOMANNAN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GENTAMICIN SULFATE; PREDNISOLONE ACETATE
4
Combination
Approved
OTHER
OPHTHALMIC
Unknown
Unknown
GENTAMICIN SULFATE; PREDNISOLONE ACETATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ADUCANUMAB-AVWA
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
ADUCANUMAB-AVWA
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CLIOQUINOL; NYSTATIN
4
Combination
Approved
OTHER
TOPICAL
Unknown
Unknown
CLIOQUINOL; NYSTATIN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TRASTUZUMAB-QYYP
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
TRASTUZUMAB-QYYP
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
COBALTOUS CHLORIDE CO 57
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
COBALTOUS CHLORIDE CO 57
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Cl2Co
Molecular Weight:
127.84
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
NORETHINDRONE ACETATE;ETHINYL ESTRADIOL;ETHINYL ESTRADIOL;FERROUS FUMARATE
4
Combination
Approved
Unknown
ORAL
Unknown
Unknown
NORETHINDRONE ACETATE;ETHINYL ESTRADIOL;ETHINYL ESTRADIOL;FERROUS FUMARATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CHLORAMPHENICOL; HYDROCORTISONE ACETATE
4
Combination
Approved
OTHER
OPHTHALMIC
Unknown
Unknown
CHLORAMPHENICOL; HYDROCORTISONE ACETATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
POTASSIUM SODIUM TARTRATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
POTASSIUM SODIUM TARTRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
QH257BPV3J
Molecule Type:
Small molecule
Molecular Formula:
C4H12KNaO10
Molecular Weight:
282.22
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
1
2
…
268
269
270
271
272
273
274
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA